APA

Nambara S., Masuda T., Nishio M., Kuramitsu S., Tobo T., Ogawa Y., Hu Q., Iguchi T., Kuroda Y., Ito S., Eguchi H., Sugimachi K., Saeki H., Oki E., Maehara Y., Suzuki A. & Mimori K. (2017). Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer. : Oncotarget.

Chicago

Nambara Sho, Masuda Takaaki, Nishio Miki, Kuramitsu Shotaro, Tobo Taro, Ogawa Yushi, Hu Qingjiang, Iguchi Tomohiro, Kuroda Yousuke, Ito Shuhei, Eguchi Hidetoshi, Sugimachi Keishi, Saeki Hiroshi, Oki Eiji, Maehara Yoshihiko, Suzuki Akira and Mimori Koshi. 2017. Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer. : Oncotarget.

Harvard

Nambara S., Masuda T., Nishio M., Kuramitsu S., Tobo T., Ogawa Y., Hu Q., Iguchi T., Kuroda Y., Ito S., Eguchi H., Sugimachi K., Saeki H., Oki E., Maehara Y., Suzuki A. and Mimori K. (2017). Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer. : Oncotarget.

MLA

Nambara Sho, Masuda Takaaki, Nishio Miki, Kuramitsu Shotaro, Tobo Taro, Ogawa Yushi, Hu Qingjiang, Iguchi Tomohiro, Kuroda Yousuke, Ito Shuhei, Eguchi Hidetoshi, Sugimachi Keishi, Saeki Hiroshi, Oki Eiji, Maehara Yoshihiko, Suzuki Akira and Mimori Koshi. Antitumor effects of the antiparasitic agent ivermectin via inhibition of Yes-associated protein 1 expression in gastric cancer. : Oncotarget. 2017.